Aim: The aim of this study was to examine the bacteria produced patients with pressure ulcers (PU) in Long-term intensive care unit (LTICU) and to evaluate the costs of antibiotherapy.
Material and Methods: We conducted a retrospective review of patients with PU in LTICU. A record included age, conditions, comorbidities, length of stay (LOS) in LTICU and prognosis. Number and location of PU, the bacteria produced in the tissue taken from the PU were also recorded. The costs of the antibiotics used for each type of bacteria were calculated and the total treatment costs for the stay in ICU were determined. A multi-variable logistic regression model was created for the variables predicted to have an effect on bacteria production in PU.
Results: A total of 142 patients were included in the study. The median LOS in LTICU was calculated as 80.1±64.8 days. The probability of E. coli production in those with a heel PU was 2.335-fold (p=0.023) and MRSA production in those with percutaneous endoscopic gastrostomy(PEG) was found to be 4.511-fold greater than in those without PEG (p=0.035). The total cost per patient was median 71817.5 Turkish liras(TL) and the antibiotic costs were observed to comprise 10.05% of the total treatment costs.
Conclusions: PU reduces quality of life of patients in LTICU, increases infection rates, antibiotherapy costs and mortality rates. The type of bacteria has an effect on antibiotherapy costs. Identification of the factors that effects costs is important and if managed this may reduce the treatment costs of patients with PU.
Key words: Pressure Ulcers; Long-Term İntensive Care Unit; Costs of Antibiotherapy.
|
